article · Journal of Molecular Structure

Evaluation of quinoxaline-2-one-hydrazone hybrid as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anticancer assessment, and in silico study

2026Al-Azhar University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Angiogenesis and VEGF in Cancer
Chemotherapy-induced cardiotoxicity and mitigation
Synthesis and biological activity

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.molstruc.2026.147239

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.